chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain in extremity, Peripheral swelling
Clinical narrative: headache; body aches; arm pain; swelling in arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (body aches), PAIN IN EXTREMITY (arm pain) and PERIPHERAL SWELLING (swelling in arm) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced HEADACHE (headache) and MYALGIA (body aches). In February 2021, the patient experienced PAIN IN EXTREMITY (arm pain) and PERIPHERAL SWELLING (swelling in arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 16-Feb-2021, HEADACHE (headache) and MYALGIA (body aches) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain) and PERIPHERAL SWELLING (swelling in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: body aches; fever of 100.5; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches) and PYREXIA (fever of 100.5) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03m20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included FUROSEMIDE, URSODIOL, AMLODIPINE BESILATE (NORVASC) and TACROLIMUS (PROGRAF) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN (body aches) and PYREXIA (fever of 100.5). At the time of the report, PAIN (body aches) and PYREXIA (fever of 100.5) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Pyrexia: 100.5 (High) 100.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: itches hot; swollen like the size of a baseball; chills; itches hot; A spontaneous report was received from a consumer, concerning a female patient of 68 years old ,who received Moderna's COVID-19 vaccine and experienced   itches hot, swollen like the size of baseball raised, chills .  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 1-mar-2021  prior to the onset of events, the patient received their second doses of mRNA-1273 (lot number 032LZ0A) via intramuscular  route for COVID-19 infection prophylaxis.   after second dose of vaccine, the patient experienced itches hot, chills, swollen like the size of baseball raised, treatment medication include Benadryl and hydrocortisone cream.  Action taken with mRNA-1273 in response to the event was not applicable.  The outcome of the event,  itches hot, chills, swollen like the size of baseball raised, was considered to be unknown at the time of this report.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Electrophoresis, Fatigue, Headache
Clinical narrative: blood spike electrophoresis; severe tiredness; swollen left arm where she got injected; headache; diarrhea; dizziness; hurt all over body; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (dizziness), PAIN (hurt all over body), ELECTROPHORESIS (blood spike electrophoresis) and VACCINATION SITE SWELLING (swollen left arm where she got injected) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0ZSADIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma. Concurrent medical conditions included Penicillin allergy. Concomitant products included VITAMIN D NOS, CENTRUM FOR WOMEN, LANSOPRAZOLE (PREVACID) and ESTRADIOL (ESTROGEN) for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DIARRHOEA (diarrhea), DIZZINESS (dizziness), PAIN (hurt all over body), VACCINATION SITE SWELLING (swollen left arm where she got injected) and HEADACHE (headache). On an unknown date, the patient experienced ELECTROPHORESIS (blood spike electrophoresis) and FATIGUE (severe tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), DIZZINESS (dizziness), PAIN (hurt all over body), ELECTROPHORESIS (blood spike electrophoresis), VACCINATION SITE SWELLING (swollen left arm where she got injected) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: New adverse event of severe tiredness
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site swelling
Clinical narrative: blood spike electrophoresis; severe tiredness; swollen left arm where she got injected; headache; diarrhea; dizziness; hurt all over body; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (dizziness), PAIN (hurt all over body), ELECTROPHORESIS (blood spike electrophoresis) and VACCINATION SITE SWELLING (swollen left arm where she got injected) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0ZSADIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma. Concurrent medical conditions included Penicillin allergy. Concomitant products included VITAMIN D NOS, CENTRUM FOR WOMEN, LANSOPRAZOLE (PREVACID) and ESTRADIOL (ESTROGEN) for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DIARRHOEA (diarrhea), DIZZINESS (dizziness), PAIN (hurt all over body), VACCINATION SITE SWELLING (swollen left arm where she got injected) and HEADACHE (headache). On an unknown date, the patient experienced ELECTROPHORESIS (blood spike electrophoresis) and FATIGUE (severe tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), DIZZINESS (dizziness), PAIN (hurt all over body), ELECTROPHORESIS (blood spike electrophoresis), VACCINATION SITE SWELLING (swollen left arm where she got injected) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: New adverse event of severe tiredness
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 03-Apr-2021. On 01-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Swelling at the injection site; Soreness at the injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Soreness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Soreness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Soreness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 032L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE, FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), MONTELUKAST SODIUM (SINGULAIR), PYRIDOSTIGMINE BROMIDE (MESTINON), MIRABEGRON, TAMSULOSIN HCL and UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (ANORO ELLIPTA) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Pyrexia: 101.7degree F. On 24-Feb-2021, Pyrexia: 103.9degree F. On 26-Feb-2021, Pyrexia: fluctuated from 97.9 to 99.8 degrees F. On 27-Feb-2021, Pyrexia: 97.5 - 99.6 degrees F. On 28-Feb-2021, Pyrexia: 97.3 - 99.7 degrees F 28Feb2021 to 1Mar2021, his temperature range was 98.1 to 100.4 degrees F. Between Mar1 to Mar2, his temperature range was 104.4 - 103.8 degrees F.. On an unknown date, Pyrexia:.         Treatment information also included cold compresses on head  Action taken with mRNA-1273 Moderna COVID-19 Vaccine was not applicable   This case was linked to MOD21-042365, MOD-2021-031515 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nightmare
Clinical narrative: A number of nightmares; Extremely tired; A spontaneous report was received from a consumer concerning a female patient of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced extremely tired and a number of nightmares.  The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.  The patient received their unspecified dose of mRNA-1273 (Batch number: Batch number not provided) on 10 Feb 2021, approximately one day prior to the onset of the symptoms via an unknown route for prophylaxis of COVID-19 infection.  On 11 Feb 2021, the patient experienced extremely tired and several nightmares. No treatment information was provided.    No relevant laboratory details were included.  Action taken with the drug in response to the events were not reported.  The outcome of the events were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Bone pain, Erythema, Pyrexia, Vaccination complication
Clinical narrative: Stomach upset; swelling; vaccination site warmth; Vaccination related malaise; red spot under their breast in the same side; every bone in thier body hurts; had a big red round spot where they got the shot; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach upset), VACCINATION SITE INFLAMMATION (swelling), VACCINATION SITE WARMTH (vaccination site warmth), VACCINATION COMPLICATION (Vaccination related malaise) and ERYTHEMA (red spot under their breast in the same side) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach upset), VACCINATION SITE INFLAMMATION (swelling), VACCINATION SITE WARMTH (vaccination site warmth), VACCINATION COMPLICATION (Vaccination related malaise), ERYTHEMA (red spot under their breast in the same side), BONE PAIN (every bone in thier body hurts), VACCINATION SITE ERYTHEMA (had a big red round spot where they got the shot) and PYREXIA (Low grade fever). At the time of the report, ABDOMINAL DISCOMFORT (Stomach upset), VACCINATION SITE INFLAMMATION (swelling), VACCINATION SITE WARMTH (vaccination site warmth), VACCINATION COMPLICATION (Vaccination related malaise), ERYTHEMA (red spot under their breast in the same side), BONE PAIN (every bone in thier body hurts), VACCINATION SITE ERYTHEMA (had a big red round spot where they got the shot) and PYREXIA (Low grade fever) outcome was unknown.            Concomitant product information was not provided by the reporter.  It was noted that the patient did not take any treatment medications but was probably going to take Aleve (naproxen) for the events.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site inflammation, Vaccination site warmth
Clinical narrative: Stomach upset; swelling; vaccination site warmth; Vaccination related malaise; red spot under their breast in the same side; every bone in thier body hurts; had a big red round spot where they got the shot; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach upset), VACCINATION SITE INFLAMMATION (swelling), VACCINATION SITE WARMTH (vaccination site warmth), VACCINATION COMPLICATION (Vaccination related malaise) and ERYTHEMA (red spot under their breast in the same side) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach upset), VACCINATION SITE INFLAMMATION (swelling), VACCINATION SITE WARMTH (vaccination site warmth), VACCINATION COMPLICATION (Vaccination related malaise), ERYTHEMA (red spot under their breast in the same side), BONE PAIN (every bone in thier body hurts), VACCINATION SITE ERYTHEMA (had a big red round spot where they got the shot) and PYREXIA (Low grade fever). At the time of the report, ABDOMINAL DISCOMFORT (Stomach upset), VACCINATION SITE INFLAMMATION (swelling), VACCINATION SITE WARMTH (vaccination site warmth), VACCINATION COMPLICATION (Vaccination related malaise), ERYTHEMA (red spot under their breast in the same side), BONE PAIN (every bone in thier body hurts), VACCINATION SITE ERYTHEMA (had a big red round spot where they got the shot) and PYREXIA (Low grade fever) outcome was unknown.            Concomitant product information was not provided by the reporter.  It was noted that the patient did not take any treatment medications but was probably going to take Aleve (naproxen) for the events.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Discomfort, Vaccination error
Clinical narrative: suffering side effects and feeling very uncomfortable; suffering side effects and feeling very uncomfortable; vaccination after 11 days of receiving plasma for COVID19; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (suffering side effects and feeling very uncomfortable), DISCOMFORT (suffering side effects and feeling very uncomfortable) and VACCINATION ERROR (vaccination after 11 days of receiving plasma for COVID19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced ADVERSE EVENT (suffering side effects and feeling very uncomfortable), DISCOMFORT (suffering side effects and feeling very uncomfortable) and VACCINATION ERROR (vaccination after 11 days of receiving plasma for COVID19). On 01-Mar-2021, VACCINATION ERROR (vaccination after 11 days of receiving plasma for COVID19) had resolved. At the time of the report, ADVERSE EVENT (suffering side effects and feeling very uncomfortable) and DISCOMFORT (suffering side effects and feeling very uncomfortable) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant information were not provided by the reporter. Treatment information were not provided by the reporter.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Fatigue, Influenza like illness, Product dose omission issue
Clinical narrative: weakness; second dose of the vaccine has been delayed until day 42; Fatigue; flu-like symptoms persisted; cough; Flu like symptoms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), INFLUENZA LIKE ILLNESS (flu-like symptoms persisted), COUGH (cough), ASTHENIA (weakness) and PRODUCT DOSE OMISSION ISSUE (second dose of the vaccine has been delayed until day 42) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history provided.).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 07-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms persisted) and COUGH (cough). On an unknown date, the patient experienced ASTHENIA (weakness), PRODUCT DOSE OMISSION ISSUE (second dose of the vaccine has been delayed until day 42) and FATIGUE (Fatigue). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), INFLUENZA LIKE ILLNESS (flu-like symptoms persisted), COUGH (cough) and FATIGUE (Fatigue) was resolving, ASTHENIA (weakness) had not resolved and PRODUCT DOSE OMISSION ISSUE (second dose of the vaccine has been delayed until day 42) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  Treatment information include Steroids, Anti-biotics, Prednisone.  The patient's doctor evaluated the patient during a Teladoc appointment and prescribed steroids and antibiotics. The patient's cough continued and the caller reported that the patient was also experiencing weakness and fatigue. During a second in-person visit, the doctor prescribed prednisone and another antibiotic. The patient's symptoms are resolving with the exception of the weakness. The patient had to delay the second dose of their vaccine and will not be getting it until the 42nd day.   Reporter did not allow further contact
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Mild fatigue; injection arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Mild fatigue) and PAIN IN EXTREMITY (injection arm soreness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (Mild fatigue) and PAIN IN EXTREMITY (injection arm soreness). At the time of the report, FATIGUE (Mild fatigue) and PAIN IN EXTREMITY (injection arm soreness) outcome was unknown. Not Provided          No Concomitant medications were reported. No Treatments were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-049781 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049781:crosslink
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Gait disturbance, Muscular weakness, Pyrexia
Clinical narrative: Could hardly walk; Weakness in her legs; Fever; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Could hardly walk), MUSCULAR WEAKNESS (Weakness in her legs) and PYREXIA (Fever) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PYREXIA (Fever). On 18-Mar-2021, the patient experienced GAIT DISTURBANCE (Could hardly walk) and MUSCULAR WEAKNESS (Weakness in her legs). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 18-Mar-2021, PYREXIA (Fever) had resolved. At the time of the report, GAIT DISTURBANCE (Could hardly walk) and MUSCULAR WEAKNESS (Weakness in her legs) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101-102 (High) 101-102 and 97.1-98.1 (Inconclusive) 97.1-98.1.         No concomitant medications were provided.    The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Hypoaesthesia, Malaise, Migraine
Clinical narrative: migraine; neck pain; some numbing stuff for the nerve; body pain; feeling really hot; really really nauseated; sicker than I was when I had COVID; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (sicker than I was when I had COVID), FEELING HOT (feeling really hot), MIGRAINE (migraine), NECK PAIN (neck pain) and HYPOAESTHESIA (some numbing stuff for the nerve) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 31M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Jan-2021.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced MALAISE (sicker than I was when I had COVID) and HEADACHE (headache). On 18-Mar-2021, the patient experienced FEELING HOT (feeling really hot), MYALGIA (body pain) and NAUSEA (really really nauseated). On an unknown date, the patient experienced MIGRAINE (migraine), NECK PAIN (neck pain) and HYPOAESTHESIA (some numbing stuff for the nerve). The patient was treated with ERENUMAB for Migraine NOS, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (sicker than I was when I had COVID), FEELING HOT (feeling really hot), NECK PAIN (neck pain), HYPOAESTHESIA (some numbing stuff for the nerve) and MYALGIA (body pain) outcome was unknown and MIGRAINE (migraine), HEADACHE (headache) and NAUSEA (really really nauseated) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  Patient stated that she took local injections in the back of her neck .   This case was linked to MOD-2021-062376 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Additional information included ERENUMAB as treatment for migraines, two more events of neck pain and numbing stuff, outcome of the headache changed from unknown to not recovered.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Neck pain
Clinical narrative: migraine; neck pain; some numbing stuff for the nerve; body pain; feeling really hot; really really nauseated; sicker than I was when I had COVID; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (sicker than I was when I had COVID), FEELING HOT (feeling really hot), MIGRAINE (migraine), NECK PAIN (neck pain) and HYPOAESTHESIA (some numbing stuff for the nerve) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 31M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Jan-2021.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced MALAISE (sicker than I was when I had COVID) and HEADACHE (headache). On 18-Mar-2021, the patient experienced FEELING HOT (feeling really hot), MYALGIA (body pain) and NAUSEA (really really nauseated). On an unknown date, the patient experienced MIGRAINE (migraine), NECK PAIN (neck pain) and HYPOAESTHESIA (some numbing stuff for the nerve). The patient was treated with ERENUMAB for Migraine NOS, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (sicker than I was when I had COVID), FEELING HOT (feeling really hot), NECK PAIN (neck pain), HYPOAESTHESIA (some numbing stuff for the nerve) and MYALGIA (body pain) outcome was unknown and MIGRAINE (migraine), HEADACHE (headache) and NAUSEA (really really nauseated) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  Patient stated that she took local injections in the back of her neck .   This case was linked to MOD-2021-062376 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Additional information included ERENUMAB as treatment for migraines, two more events of neck pain and numbing stuff, outcome of the headache changed from unknown to not recovered.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Hypersensitivity, Urticaria
Clinical narrative: Hives on arm, legs and back; Burning tongue and chest; Allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives on arm, legs and back), BURNING SENSATION (Burning tongue and chest) and HYPERSENSITIVITY (Allergic reaction) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included TAMOXIFEN for Hormone therapy, HYDROXYZINE for Itching, TRAMADOL for Pain, APIXABAN (ELIQUIS) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced URTICARIA (Hives on arm, legs and back), BURNING SENSATION (Burning tongue and chest) and HYPERSENSITIVITY (Allergic reaction). At the time of the report, URTICARIA (Hives on arm, legs and back), BURNING SENSATION (Burning tongue and chest) and HYPERSENSITIVITY (Allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided by the reporter.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Constipation, Pain in extremity
Clinical narrative: Arm little sore; Constipated; Stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm little sore), CONSTIPATION (Constipated) and ABDOMINAL PAIN UPPER (Stomach cramps) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included VITAMINS NOS and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for an unknown indication.    On 16-Mar-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm little sore), CONSTIPATION (Constipated) and ABDOMINAL PAIN UPPER (Stomach cramps). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) at an unspecified dose and frequency and TILACTASE (LACTAID) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm little sore) outcome was unknown and CONSTIPATION (Constipated) and ABDOMINAL PAIN UPPER (Stomach cramps) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Oropharyngeal pain, Pyrexia
Clinical narrative: Fever; tired; coughing; sore throat; This spontaneous case was reported by a pharmacist and describes the occurrence of COUGH (coughing), OROPHARYNGEAL PAIN (sore throat), PYREXIA (Fever) and FATIGUE (tired) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced COUGH (coughing) and OROPHARYNGEAL PAIN (sore throat). On 18-Mar-2021, the patient experienced PYREXIA (Fever). 18-Mar-2021, the patient experienced FATIGUE (tired). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 2 Motrin tablets about 12 hours after dose and another dose 4 hours later and third dose the next day. At the time of the report, COUGH (coughing), OROPHARYNGEAL PAIN (sore throat), PYREXIA (Fever) and FATIGUE (tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm AFTER FIRST DOSE) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 047A21A) for COVID-19 vaccination. The patient's past medical history included Accident automobile (had an injury from a car accident and normally gets numbing and tingly in the arm.). On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm AFTER FIRST DOSE). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and LORATADINE (CLARITINE) at an unspecified dose and frequency. On 12-Feb-2021, PAIN IN EXTREMITY (Sore arm AFTER FIRST DOSE) had resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Herpes zoster
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Diagnosed with shingles) and HEADACHE (headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. Concurrent medical conditions included Shingles (always on her back). On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced HERPES ZOSTER (Diagnosed with shingles) and HEADACHE (headache). The patient was treated with VALACYCLOVIR [VALACICLOVIR] for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Diagnosed with shingles) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. After receiving the vaccine, patient had headache, lips tingling a little bit upon touching, and then later that night the right side of her face was breaking out with blisters, went to emergency room where she was diagnosed with shingles and prescribed with Valacyclovir, and at the time of this report the patient's blisters were drying up.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Interval between doses (55 days); This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Interval between doses (55 days)) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and Lot # 006B21A),) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Interval between doses (55 days)). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Interval between doses (55 days)) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was Not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Laziness, Pain in extremity
Clinical narrative: sore arm; lazy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and LAZINESS (lazy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and LAZINESS (lazy). At the time of the report, PAIN IN EXTREMITY (sore arm) and LAZINESS (lazy) outcome was unknown.            No concomitant medications were provided. No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Non significant follow up , Contact information updated.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: Feels dizzy; Extreme fatigue; Nausea; Diarrhea; Headache on right side of head; Fatigue; Injection arm developed soreness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Feels dizzy), PAIN IN EXTREMITY (Injection arm developed soreness), DIARRHEA (Diarrhea), HEADACHE (Headache on right side of head) and FATIGUE (Fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (Injection arm developed soreness) and FATIGUE (Fatigue). On 14-Mar-2021, the patient experienced DIARRHEA (Diarrhea), HEADACHE (Headache on right side of head) and NAUSEA (Nausea). On 18-Mar-2021, the patient experienced DIZZINESS (Feels dizzy) and FATIGUE (Extreme fatigue). In March 2021, PAIN IN EXTREMITY (Injection arm developed soreness), DIARRHEA (Diarrhea), HEADACHE (Headache on right side of head), FATIGUE (Fatigue) and NAUSEA (Nausea) had resolved. At the time of the report, DIZZINESS (Feels dizzy) and FATIGUE (Extreme fatigue) outcome was unknown.            Concomitant product used was reported as glaucoma eye drops NOS Treatment information was not provided by the reporter   This case was linked to US-MODERNATX, INC.-MOD-2021-049766 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049766:crosslink
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Feels dizzy; Extreme fatigue; Nausea; Diarrhea; Headache on right side of head; Fatigue; Injection arm developed soreness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Feels dizzy), PAIN IN EXTREMITY (Injection arm developed soreness), DIARRHEA (Diarrhea), HEADACHE (Headache on right side of head) and FATIGUE (Fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (Injection arm developed soreness) and FATIGUE (Fatigue). On 14-Mar-2021, the patient experienced DIARRHEA (Diarrhea), HEADACHE (Headache on right side of head) and NAUSEA (Nausea). On 18-Mar-2021, the patient experienced DIZZINESS (Feels dizzy) and FATIGUE (Extreme fatigue). In March 2021, PAIN IN EXTREMITY (Injection arm developed soreness), DIARRHEA (Diarrhea), HEADACHE (Headache on right side of head), FATIGUE (Fatigue) and NAUSEA (Nausea) had resolved. At the time of the report, DIZZINESS (Feels dizzy) and FATIGUE (Extreme fatigue) outcome was unknown.            Concomitant product used was reported as glaucoma eye drops NOS Treatment information was not provided by the reporter   This case was linked to US-MODERNATX, INC.-MOD-2021-049766 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049766:crosslink
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia
Clinical narrative: could not sleep , tossing and turning all night; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep , tossing and turning all night) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced INSOMNIA (could not sleep , tossing and turning all night). At the time of the report, INSOMNIA (could not sleep , tossing and turning all night) outcome was unknown.            Treatment for the event was not provided. No concomitant medications were reported
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Coming and going rash on right Hand; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Coming and going rash on right Hand) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced RASH (Coming and going rash on right Hand). At the time of the report, RASH (Coming and going rash on right Hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia
Clinical narrative: Loss sense of smell; This spontaneous case was reported by a pharmacist and describes the occurrence of ANOSMIA (Loss sense of smell) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced ANOSMIA (Loss sense of smell). At the time of the report, ANOSMIA (Loss sense of smell) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Depression, Dry mouth, Nausea, Oral candidiasis
Clinical narrative: Pruritus; Like her skin is very sensitive to anything that is touching it; It worried her/has so much anxiety over this; Itchy mouth; Thrush in mouth; Her mouth gets really dry; A little bit of nausea; This is very depressing; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Pruritus), SENSITIVE SKIN (Like her skin is very sensitive to anything that is touching it), ANXIETY (It worried her/has so much anxiety over this), ORAL PRURITUS (Itchy mouth) and ORAL CANDIDIASIS (Thrush in mouth) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hormone replacement therapy. Concomitant products included ESTROGENS CONJUGATED, MEDROXYPROGESTERONE ACETATE (PREMPRO), FAMOTIDINE (PEPCID [FAMOTIDINE]) and LORAZEPAM for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PRURITUS (Pruritus), SENSITIVE SKIN (Like her skin is very sensitive to anything that is touching it), ANXIETY (It worried her/has so much anxiety over this), ORAL PRURITUS (Itchy mouth), ORAL CANDIDIASIS (Thrush in mouth), DRY MOUTH (Her mouth gets really dry), NAUSEA (A little bit of nausea) and DEPRESSION (This is very depressing). The patient was treated with SALICYLIC ACID (EUCERIN [SALICYLIC ACID]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Pruritus), SENSITIVE SKIN (Like her skin is very sensitive to anything that is touching it), ANXIETY (It worried her/has so much anxiety over this), ORAL PRURITUS (Itchy mouth), ORAL CANDIDIASIS (Thrush in mouth), DRY MOUTH (Her mouth gets really dry), NAUSEA (A little bit of nausea) and DEPRESSION (This is very depressing) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported itching were in odd spots, behind her knee, back of neck, hands, bend of her hands, in really weird places and felt very horrible. Patient used an unspecified anti-itch cream for the treatment of the events.   According to the latest follow-up conditions still persisted but she felt slightly better.   Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2021: Reporter information, medical history, event Information and treatment medicine updated. On 06-Apr-2021: Update on outcome of events. On 09-Apr-2021: Events outcome updated.